The product automatically prepares blood samples for immediate testing and post-analytical processing utilising intelligent robotics. Moreover, the solution is twice as fast in terms of processing speed as the company's previous similar product. Cobas 8100 can also be added onto existing cobas analysers, Roche noted.
According to Roche Diagnostics chief operating officer, Roland Diggelmann, the new system will reduce the lab costs and improve productivity, while simultaneously decreasing the risk of sample mix-ups or contamination due to manual handling.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia